These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 425668)

  • 21. [Clinical studies on the effect of hexobendine (Ustimon) on cerebral circulatory disorders].
    Prosenz P; Tschabitscher H
    Wien Klin Wochenschr; 1965 Dec; 77(48):953-5. PubMed ID: 5331101
    [No Abstract]   [Full Text] [Related]  

  • 22. Contributions of vasoactive substances in cases of chronic arteriosclerotic occlusion in the lower extremities.
    Numata M
    Methods Find Exp Clin Pharmacol; 1982; 4(3):199-202. PubMed ID: 7121130
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prognosis of the length of remission following conservative treatment of atherosclerotic occlusions of the main arteries of the extremities].
    Shishkin EK; Shcherbiuk AN; Ginzburg LS; Lemenev VL; El'kov AN
    Sov Med; 1988; (11):65-7. PubMed ID: 3238515
    [No Abstract]   [Full Text] [Related]  

  • 24. [The therapy of peripheral circulatory disorders (angiooganopathies) with a blood extract].
    Schirren C; Dietrich K; Biel F
    Hautarzt; 1967 Jun; 18(6):260-4. PubMed ID: 5593511
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of functional changes in arteriosclerotic chronic obliterating peripheral arterial diseases (COPA) and Buerger's and Raynaud's diseases with pharmacological sympathicolysis, with or without indirect surgical treatment].
    Bagliani A; Borri P; Taborelli R
    Minerva Cardioangiol; 1973 Jun; 21(6):439-52. PubMed ID: 4720185
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cinnarizine and phosphatidyl choline in the treatment of cerebral arteriosclerotic pathology and arteriosclerosis of the lower extremities. Comparative study].
    Ciammaichella A; Solitro A; Arcuri P
    Minerva Cardioangiol; 1975 Mar; 23(3):191-200. PubMed ID: 1128771
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinico-hemodynamic evaluation of the efficacy of vasoactive and cardiotonic agents in the combined treatment of arteriosclerosis patients with chronic cerebral circulatory insufficiency].
    Ishchenko MM; Dorogiĭ AN; Nechaĭ EE; Shkrobot SI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(9):1313-20. PubMed ID: 3425072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An electrodiagnostic study in arteriosclerotic peripheral vascular disease.
    Chaco J
    Electroencephalogr Clin Neurophysiol; 1968 Feb; 24(2):193. PubMed ID: 4170507
    [No Abstract]   [Full Text] [Related]  

  • 29. [Nonsurgical treatment of obliterative atherosclerosis of the lower extremities].
    Lorentsen E
    Tidsskr Nor Laegeforen; 1979 Aug; 99(24):1137-8. PubMed ID: 531805
    [No Abstract]   [Full Text] [Related]  

  • 30. [Plasma phosphatides in arteriosclerotic occlusions in the arteries of extremities].
    Jipp P
    Dtsch Med Wochenschr; 1969 Mar; 94(11):530-4. PubMed ID: 5766154
    [No Abstract]   [Full Text] [Related]  

  • 31. [Conservative treatment and prevention of arteriosclerosis].
    Schmid HJ
    Helv Chir Acta; 1971 Apr; 38(1):73-7. PubMed ID: 4103070
    [No Abstract]   [Full Text] [Related]  

  • 32. [Results of a clinical study on the vasodilator 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191)].
    Lehrach F; Müller R
    Arzneimittelforschung; 1971 Aug; 21(8):1171-4. PubMed ID: 5110012
    [No Abstract]   [Full Text] [Related]  

  • 33. Medical and surgical treatment of peripheral arteriosclerotic vascular disease.
    Young JR; Beven EG
    Cardiovasc Clin; 1981; 12(2):137-41. PubMed ID: 6212119
    [No Abstract]   [Full Text] [Related]  

  • 34. [Ambulant treatment of arteriosclerotic blood circulation disorders with Na 2-EDTA].
    Zielke A; Bolland G; Völkner E; Roth J; Bauer B
    Dtsch Gesundheitsw; 1966 Feb; 21(5):215-22. PubMed ID: 4961122
    [No Abstract]   [Full Text] [Related]  

  • 35. [Forms of development of arteriosclerotic circulation disorders in the extremities].
    SINGER R
    Wien Klin Wochenschr; 1953 Mar; 65(11):214-6. PubMed ID: 13078308
    [No Abstract]   [Full Text] [Related]  

  • 36. [The treatment of retinal circulatory disorders in practice. A contribution to the cooperation between the internist and the ophthalmologist].
    Zielinski HW
    Munch Med Wochenschr; 1965 Dec; 107(50):2560-4. PubMed ID: 5331159
    [No Abstract]   [Full Text] [Related]  

  • 37. [Possibilities and limitations in the diagnosis and therapy of peripheral arterial circulatory disorders in ambulatory practice].
    Kamp O
    Z Arztl Fortbild (Jena); 1977 Feb; 71(3):126-31. PubMed ID: 848061
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of sulodexide on hemorheological parameters in a group of patients with peripheral arteriosclerotic vascular disease].
    Calabrò A; Rossi A; Baiocchi MR; Coscetti G; Fellin R; Crepaldi G
    Ric Clin Lab; 1985; 15 Suppl 1():455-63. PubMed ID: 4035227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Conservative treatment of atherosclerotic ischemia of the lower extremities].
    Stadnik J; Cieślik R; Szczechowski K; Sadliński C
    Pol Tyg Lek; 1974 Mar; 29(11):437-9. PubMed ID: 4822184
    [No Abstract]   [Full Text] [Related]  

  • 40. [Rheographic studies of the peripheral vasodilating action of Halidor].
    Kusztos D
    Orv Hetil; 1968 May; 109(21):Suppl:29-31. PubMed ID: 5720719
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.